Company Filing History:
2 out of 90 
2 out of 26 
1 out of 2,078 
Years Active: 1998-2002
Title: Ulrich Conrad Dyer: Innovator in Anaesthetic Agent Manufacturing
Introduction
Ulrich Conrad Dyer is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of anaesthetic agents, particularly through his innovative processes in the manufacture of levobupivacaine and related compounds. With a total of five patents to his name, Dyer's work has had a substantial impact on the pharmaceutical industry.
Latest Patents
Dyer's latest patents include a racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents. This process involves an optically-enriched piperidine-2-carboxanilide compound, which is racemized by heating in an aqueous medium that includes an organic co-solvent if the compound is N-alkylated. This method is particularly valuable when combined with a resolution process for the production of levobupivacaine. Another significant patent focuses on the racemization of precursors to levobupivacaine and analogues thereof. This process prepares optically-enriched pipecolic acid as a salt with an optically-active acid, utilizing asymmetric transformation in a solvent that promotes racemisation.
Career Highlights
Throughout his career, Dyer has worked with several prominent companies, including Darwin Discovery Limited and Chiroscience Ltd. His expertise in the field has allowed him to develop innovative processes that enhance the efficiency and effectiveness of anaesthetic manufacturing.
Collaborations
Dyer has collaborated with notable professionals in the industry, including Martin Woods and Raymond McCague. These partnerships have contributed to the advancement of his research and the successful implementation of his patented processes.
Conclusion
Ulrich Conrad Dyer's contributions to the field of anaesthetic agents through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and improve the manufacturing processes of essential medical compounds.